Skip to main content
Erschienen in: Journal of Clinical Immunology 8/2022

18.08.2022 | Original Article

High Inborn Errors of Immunity Risk in Patients with Granuloma

verfasst von: Merve Süleyman, Oğuzhan Serin, Büşra Koçali, Diclehan Orhan, Elmas Ebru Yalçın, Uğur Özçelik, Mehmet Ceyhan, Nural Kiper, İlhan Tezcan, Deniz Dogru, Deniz Çağdaş

Erschienen in: Journal of Clinical Immunology | Ausgabe 8/2022

Einloggen, um Zugang zu erhalten

Abstract

Objective

Granuloma etiology includes infections, vasculitis, chemicals, malignancies, lymphoproliferative disorders, and immunological diseases. We hypothesized that patients with granuloma have an underlying primary immunodeficiency disease (PIDD).

Patients and Methods

We retrospectively enrolled 82 patients with immunological evaluation among 294 biopsy-proven granuloma patients (0- to 20-year-old). At the same time frame, we followed up with 1910 patients in the same age group.

Results

Out of 82 patients, male/female ratio was 45/37. Median age at symptom onset was 5 years (28 days–17.4 years), age of granuloma at diagnosis was 8.6 years (36 days–19.4 years). Common symptoms at disease onset were fever (23.2%), lymphadenopathy (19.6%), abdominal pain (12.2%), and cough (12.2%). Granuloma was frequent in lymph nodes (26.8%), skin (19.5%), lung (13.4%), and bone (11%). Common infectious agents isolated were Mycobacterium spp. (23.2%) and EBV (4.9%).
We document PIDD in 76.8% (63/82) of patients. 49.4% (40/81) of immunologically evaluated granuloma patients had hypogammaglobulinemia. Granuloma rate in pediatric PIDD was 3.3%(63/1910).
Patients with multiple granulomas (n = 16) had a PIDD diagnosis. Lung involvement was three times more in PIDD. Brain involvement was only seen in PIDD. Fibroadipose tissue and liver involvement were more frequent in patients without documented PIDD and patients whose evaluation was not completed.
The mortality rate in PIDD with granuloma was 15.9%, whereas there was no mortality in patients without PIDD.

Conclusion

As documented here, even in a university hospital, the immunologic evaluation ratio is about one-third. We showed high PIDD frequency in children with granuloma, and higher mortality in PIDD with granuloma. Thus, an immunologic evaluation performed meticulously by immunologists is a must for accurate diagnosis and decision of individualized therapeutic options.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Bousfiha A, Jeddane L, Picard C, et al. Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification. J Clin Immunol. 2020;40:66–81. CrossRefPubMedPubMedCentral Bousfiha A, Jeddane L, Picard C, et al. Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification. J Clin Immunol. 2020;40:66–81. CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Leung J, Sullivan KE, Perelygina L, Icenogle JP, Fuleihan RL, Lanzieri TM. Prevalence of granulomas in patients with primary ımmunodeficiency disorders, United States: data from National Health Care Claims and the US Immunodeficiency Network Registry. J Clin Immunol. 2018;38:717–26. CrossRefPubMedPubMedCentral Leung J, Sullivan KE, Perelygina L, Icenogle JP, Fuleihan RL, Lanzieri TM. Prevalence of granulomas in patients with primary ımmunodeficiency disorders, United States: data from National Health Care Claims and the US Immunodeficiency Network Registry. J Clin Immunol. 2018;38:717–26. CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Siegfried EC, Prose NS, Friedman NJ, Paller AS. Cutaneous granulomas in children with combined immunodeficiency. J Am Acad Dermatol. 1991;25:761–6. CrossRefPubMed Siegfried EC, Prose NS, Friedman NJ, Paller AS. Cutaneous granulomas in children with combined immunodeficiency. J Am Acad Dermatol. 1991;25:761–6. CrossRefPubMed
6.
Zurück zum Zitat Keczkes K, Bilimoria S, Piercy DM. Pernicious anaemia and granulomatous skin lesions in a case of common variable hypogammaglobulinaemia. Br J Dermatol. 1979;101:211–7. CrossRefPubMed Keczkes K, Bilimoria S, Piercy DM. Pernicious anaemia and granulomatous skin lesions in a case of common variable hypogammaglobulinaemia. Br J Dermatol. 1979;101:211–7. CrossRefPubMed
7.
Zurück zum Zitat Paller AS, Massey RB, Curtis MA, et al. Cutaneous granulomatous lesions in patients with ataxiatelangiectasia. J Pediatr. 1991;119:917–22. CrossRefPubMed Paller AS, Massey RB, Curtis MA, et al. Cutaneous granulomatous lesions in patients with ataxiatelangiectasia. J Pediatr. 1991;119:917–22. CrossRefPubMed
8.
Zurück zum Zitat Fleming MG, Gewurz AT, Pearson RW. Caseating cutaneous granulomas in a patient with Xlinked infantile hypogammaglobulinemia. J Am Acad Dermatol. 1991;24:629–33. CrossRefPubMed Fleming MG, Gewurz AT, Pearson RW. Caseating cutaneous granulomas in a patient with Xlinked infantile hypogammaglobulinemia. J Am Acad Dermatol. 1991;24:629–33. CrossRefPubMed
9.
Zurück zum Zitat Pierson JC, Camisa C, Lawlor KB, Elston DM. Cutaneous and visceral granulomas in common variable immunodeficiency. Cutis. 1993;52:221–2. PubMed Pierson JC, Camisa C, Lawlor KB, Elston DM. Cutaneous and visceral granulomas in common variable immunodeficiency. Cutis. 1993;52:221–2. PubMed
10.
Zurück zum Zitat Harp J, Coggshall K, Ruben BS, Ramírez-Valle F, He SY, Berger TG. Cutaneous granulomas in the setting of primary immunodeficiency: a report of four cases and review of the literature. Int J Dermatol. 2015;54:617–25. CrossRefPubMed Harp J, Coggshall K, Ruben BS, Ramírez-Valle F, He SY, Berger TG. Cutaneous granulomas in the setting of primary immunodeficiency: a report of four cases and review of the literature. Int J Dermatol. 2015;54:617–25. CrossRefPubMed
12.
Zurück zum Zitat Ramakrishnan L. Revisiting the role of the granuloma in tuberculosis. Nat Rev Immunol. 2012;12:352–66. CrossRefPubMed Ramakrishnan L. Revisiting the role of the granuloma in tuberculosis. Nat Rev Immunol. 2012;12:352–66. CrossRefPubMed
13.
Zurück zum Zitat Kumar V, Abul KA, and Aster JC. Robbins and Cotran pathologic basis of disease. Ninth edition. Philadelphia, PA: Elsevier/Saunders. 2015. Kumar V, Abul KA, and Aster JC. Robbins and Cotran pathologic basis of disease. Ninth edition. Philadelphia, PA: Elsevier/Saunders. 2015.
17.
Zurück zum Zitat Koçali B., Evaluating the diagnosis and clinical features of the patients who followed up with primary ımmunodeficiency diagnosis in Hacettepe University İhsan Doğramacı Children’s Hospital Pediatric Immunology Department, Hacettepe University Faculty of Medicine Department of Pediatrics, Thesis in Pediatrics, Ankara. 2020. Koçali B., Evaluating the diagnosis and clinical features of the patients who followed up with primary ımmunodeficiency diagnosis in Hacettepe University İhsan Doğramacı Children’s Hospital Pediatric Immunology Department, Hacettepe University Faculty of Medicine Department of Pediatrics, Thesis in Pediatrics, Ankara. 2020.
22.
Zurück zum Zitat Ekinci A., Evaluation and comparison of peripherale blood lymphocyte functions in healty children by using two different methods, Ankara Unıversıty Bıotechnology Instıtute, Postgraduate Thesis, Ankara, 2006. Ekinci A., Evaluation and comparison of peripherale blood lymphocyte functions in healty children by using two different methods, Ankara Unıversıty Bıotechnology Instıtute, Postgraduate Thesis, Ankara, 2006.
25.
Zurück zum Zitat Rose CD, Neven B, Wouters C. Granulomatous inflammation: the overlap of immune deficiency and inflammation. Best Pract Res Clin Rheumatol. 2014;28:191–212. CrossRefPubMed Rose CD, Neven B, Wouters C. Granulomatous inflammation: the overlap of immune deficiency and inflammation. Best Pract Res Clin Rheumatol. 2014;28:191–212. CrossRefPubMed
27.
Zurück zum Zitat Chiam LY, Verhagen MM, Haraldsson A, et al. Cutaneous granulomas in ataxia telangiectasia and other primary immunodeficiencies: reflection of inappropriate immune regulation? Dermatology (Basel, Switzerland). 2011;223:13–9. CrossRefPubMed Chiam LY, Verhagen MM, Haraldsson A, et al. Cutaneous granulomas in ataxia telangiectasia and other primary immunodeficiencies: reflection of inappropriate immune regulation? Dermatology (Basel, Switzerland). 2011;223:13–9. CrossRefPubMed
30.
Zurück zum Zitat Doğru D, Kiper N, Ozçelik U, Yalçin E, Tezcan I. Tuberculosis in children with congenital immunodeficiency syndromes. Tuberkuloz ve toraks. 2010;58:59–63. PubMed Doğru D, Kiper N, Ozçelik U, Yalçin E, Tezcan I. Tuberculosis in children with congenital immunodeficiency syndromes. Tuberkuloz ve toraks. 2010;58:59–63. PubMed
32.
Zurück zum Zitat Chiang SS, Swanson DS, Starke JR. New diagnostics for childhood tuberculosis. Infect Dis Clin North Am. 2015;29:477–502. CrossRefPubMed Chiang SS, Swanson DS, Starke JR. New diagnostics for childhood tuberculosis. Infect Dis Clin North Am. 2015;29:477–502. CrossRefPubMed
33.
Zurück zum Zitat Seger RA. Advances in the diagnosis and treatment of chronic granulomatous disease. Curr Opinion Hematol. 2011;18. Seger RA. Advances in the diagnosis and treatment of chronic granulomatous disease. Curr Opinion Hematol. 2011;18.
35.
Zurück zum Zitat Falcone EL, Zelazny AM, Holland SM. Rothia aeria neck abscess in a patient with chronic granulomatous disease: case report and brief review of the literature. J Clin Immunol. 2012;32:1400–3. CrossRefPubMedPubMedCentral Falcone EL, Zelazny AM, Holland SM. Rothia aeria neck abscess in a patient with chronic granulomatous disease: case report and brief review of the literature. J Clin Immunol. 2012;32:1400–3. CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Morgan EA, Henrich TJ, Jarell AD, et al. Infectious granulomatous dermatitis associated with Rothia mucilaginosa bacteremia: a case report. Am J Dermatopathol. 2010;32:175–9. CrossRefPubMed Morgan EA, Henrich TJ, Jarell AD, et al. Infectious granulomatous dermatitis associated with Rothia mucilaginosa bacteremia: a case report. Am J Dermatopathol. 2010;32:175–9. CrossRefPubMed
37.
Zurück zum Zitat Tsukamoto N, Handa H, Yokohama A, et al. Long-term follow-up of EBV-positive lymphoproliferative disorders in a patient with systemic lupus erythematosus. Med Mol Morphol. 2011;44:237–41. CrossRefPubMed Tsukamoto N, Handa H, Yokohama A, et al. Long-term follow-up of EBV-positive lymphoproliferative disorders in a patient with systemic lupus erythematosus. Med Mol Morphol. 2011;44:237–41. CrossRefPubMed
38.
Zurück zum Zitat Gangar P, Venkatarajan S. Granulomatous lymphoproliferative disorders: granulomatous slack skin and lymphomatoid granulomatosis. Dermatol Clin. 2015;33:489–96. CrossRefPubMed Gangar P, Venkatarajan S. Granulomatous lymphoproliferative disorders: granulomatous slack skin and lymphomatoid granulomatosis. Dermatol Clin. 2015;33:489–96. CrossRefPubMed
39.
Zurück zum Zitat Reyes C, Abuzaitoun O, De Jong A, Hanson C, Langston C. Epstein-Barr virus-associated smooth muscle tumors in ataxia-telangiectasia: a case report and review. Hum Pathol. 2002;33:133–6. CrossRefPubMed Reyes C, Abuzaitoun O, De Jong A, Hanson C, Langston C. Epstein-Barr virus-associated smooth muscle tumors in ataxia-telangiectasia: a case report and review. Hum Pathol. 2002;33:133–6. CrossRefPubMed
40.
Zurück zum Zitat McClain KL, Leach CT, Jenson HB, et al. Association of Epstein-Barr virus with leiomyosarcomas in young people with AIDS. N Engl J Med. 1995;332:12–8. CrossRefPubMed McClain KL, Leach CT, Jenson HB, et al. Association of Epstein-Barr virus with leiomyosarcomas in young people with AIDS. N Engl J Med. 1995;332:12–8. CrossRefPubMed
41.
Zurück zum Zitat Ardeniz O, Cunningham-Rundles C. Granulomatous disease in common variable immunodeficiency. Clin Immunol (Orlando, Fla). 2009;133:198–207. CrossRef Ardeniz O, Cunningham-Rundles C. Granulomatous disease in common variable immunodeficiency. Clin Immunol (Orlando, Fla). 2009;133:198–207. CrossRef
42.
Zurück zum Zitat Mullighan CG, Fanning GC, Chapel HM, Welsh KI. TNF and lymphotoxin-alpha polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous disease. J Immunol. 1997;159:6236–41. PubMed Mullighan CG, Fanning GC, Chapel HM, Welsh KI. TNF and lymphotoxin-alpha polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous disease. J Immunol. 1997;159:6236–41. PubMed
43.
Zurück zum Zitat Kliegman R. Nelson Textbook of Pediatrics. Edition 21. Philadelphia, PA: Elsevier. 2020. Kliegman R. Nelson Textbook of Pediatrics. Edition 21. Philadelphia, PA: Elsevier. 2020.
45.
Zurück zum Zitat Caka C, Cimen O, Kahyaoğlu P, Tezcan İ, Cagdas D. Selective IgM deficiency: follow-up and outcome. Pediatr Allergy Immunol. 2021;32:1327–34. CrossRefPubMed Caka C, Cimen O, Kahyaoğlu P, Tezcan İ, Cagdas D. Selective IgM deficiency: follow-up and outcome. Pediatr Allergy Immunol. 2021;32:1327–34. CrossRefPubMed
46.
Zurück zum Zitat van Stigt AC, Dik WA, Kamphuis LSJ, et al. What works when treating granulomatous disease in genetically undefined CVID? A Syst Rev Front Immunol. 2020;11:606389. CrossRef van Stigt AC, Dik WA, Kamphuis LSJ, et al. What works when treating granulomatous disease in genetically undefined CVID? A Syst Rev Front Immunol. 2020;11:606389. CrossRef
Metadaten
Titel
High Inborn Errors of Immunity Risk in Patients with Granuloma
verfasst von
Merve Süleyman
Oğuzhan Serin
Büşra Koçali
Diclehan Orhan
Elmas Ebru Yalçın
Uğur Özçelik
Mehmet Ceyhan
Nural Kiper
İlhan Tezcan
Deniz Dogru
Deniz Çağdaş
Publikationsdatum
18.08.2022
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 8/2022
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-022-01342-1

Weitere Artikel der Ausgabe 8/2022

Journal of Clinical Immunology 8/2022 Zur Ausgabe

Update Innere Medizin

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.